Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Auditory, vestibular and visual disorders of ischaemic aetiology Age: Adult |
Dose: Tablet – 1 tablet (almitrine 30 mg and raubasine 10 mg) Frequency: twice daily Note: Administered by mouth. |
|
Indication: Cerebrovascular insufficiency Age: Adult |
Dose: Tablet – 1 tablet (almitrine 30 mg and raubasine 10 mg) Frequency: twice daily Note: Administered by mouth. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: Tablet – No approved pediatric dosage available Note: No approved pediatric dosage available |
Administration
- Follow doctor's instructions
- Take as prescribed
Side Effect
- Mild GI disorders
- sleep disturbances
- palpitations
- anxiety
- dizziness
- weight loss
- peripheral neuropathy with abnormal sensations in the lower limbs
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Other almitrine-containing preparations
|
Should not be used concurrently
|
|
MAOIs (Phenelzine, Tranylcypromine, Selegiline, Moclobemide)
|
Potentially Fatal interaction
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at a cool and dry place, protected from light and moisture. Keep out of reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.